One‐Year Outcomes with the TAXUS Liberté Stent in the Real World: The TAXUS OLYMPIA Registry (Phase I)
Rattachement africain : sa, my, kw, ae, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: The TAXUS OLYMPIA registry is a prospective, postapproval registry collecting clinical outcomes data on patients receiving the TAXUS Liberté paclitaxel‐eluting stent during routine interventional cardiology practice. Methods: Between February and July 2005, 529 patients receiving the TAXUS Liberté stent at 16 centers in the Middle East, South/Central America, and Asia/Pacific regions were enrolled in Phase I of OLYMPIA. The primary end‐point was TAXUS Liberté stent‐related cardiac events (cardiac death, MI, and revascularization) at 30 days postimplant. Additional clinical assessment was conducted at 6 and 12 months. OLYMPIA phases II and III are in clinical follow‐up and will be reported separately. Results: One‐year clinical follow‐up is available for 98% of patients. Complex patients and lesions were prevalent, including: 50% diabetes mellitus, 49% multivessel disease, 30% multiple stenting, 48% AHA/ACC type B2/C lesions, 19% long lesions (>26 mm), and 40% small vessels (≤2.75 mm). At 1 year, the cardiac event rate was 4.1%, including 1.5% cardiac death, 1.5% MI, and 2.3% target vessel revascularization (TVR). The TAXUS Liberté stent‐related cardiac event rate was 3.7% at 1 year. Stent thrombosis (ST) occurred in 1.7% of patients, with three cases occurring >30 days postprocedure. One‐year cardiac event rates among complex subpopulations (diabetics 5.0%, multiple stents 3.8%, long lesions 3.1%, and small vessels 2.9%) were comparable to the overall study population. Conclusions: In conclusion, this first report of real‐world experience with the TAXUS Liberté stent demonstrates the safety and clinical utility of this stent in the broader spectrum of coronary disease treated in everyday practice.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- One‐Year Outcomes with the TAXUS Liberté Stent in the Real World: The TAXUS OLYMPIA Registry (Phase I)
- Date Crossref
- 18/11/2008
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
King Fahd Armed Forces Hospital pays non établi dans la noticeÉtablissement de santé
-
Armed Forces Hospital pays non établi dans la noticeÉtablissement de santé
-
National Heart Institute pays non établi dans la noticeStructure de recherche
-
Chest Diseases Hospital pays non établi dans la noticeÉtablissement de santé
-
Zayed Military Hospital pays non établi dans la noticeÉtablissement de santé
-
Boston Scientific (United States) pays non établi dans la noticeEntreprise
-
Instit Jantung Negara pays non établi dans la noticeInstitution
-
Chest Hospital pays non établi dans la noticeÉtablissement de santé
-
Bahrain Defence Force Royal Medical Services pays non établi dans la noticeInstitution
-
Boston Scientific Corporation pays non établi dans la noticeInstitution
King Fahd Armed Forces Hospital, Armed Forces Hospital et National Heart Institute, avec 7 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.